A prospective study comparing injectable interferon beta-1a (Rebif 22-44), (Avonex 30) and 1b (Betaseron 250) injection site reaction in multiple sclerosis patients

by Foziah Jabbar Alshamrani, Hind Alnajashi, Fahad Alkhamis, Ibrahim Alghanimi, Abdulla Alsulaiman, Aishah Albaker, Iqbal bukari, Amir Mohamad
Published 2019-09-01